About this trial
Acute kidney injury (AKI) is a significant postoperative complication. Risk factors for AKI include impaired renal perfusion, decreased functional renal reserve, as well as advanced age, peripheral arterial disease, diabetes mellitus, renovascular disease and congestive heart failure. Mean arterial pressure (MAP) below 55-60 mmHg has been associated with postoperative AKI. Traditional diagnostic criteria for AKI include increased serum creatinine levels and oliguria. However, creatinine levels do not rise until more than half of renal function is lost. Serum and urine NGAL levels rise earlier-within 24-48 hours-making it a promising early biomarker.
In our study, hypotension is defined as systolic blood pressure \<100 mmHg or a \>30% decrease in MAP. Patients requiring ephedrine under these conditions will be evaluated as the hypotension group and compared with non-hypotensive patients in terms of NGAL, BUN (blood urea nitrogen), creatinine, and GFR (Glomerular Filtration Rate) values at baseline and at the 4th postoperative hour.
Eligibility criteria
Qualifiers
Patients classified as ASA physical status II-III
Pregnant women aged 18-45 years, diagnosed with preeclampsia and scheduled for elective cesarean section, will be included in the study.
Disqualifiers
Patients who are unable to read, understand, or sign the informed consent form
Patients with a diagnosed renal disease
Patients who do not wish to participate in the study
Patients with ASA physical status greater than III
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Nihan Aydin Guzey
Lead sponsor
Ankara City Hospital Bilkent
Sponsor institution
Ankara City Hospital Bilkent
Collaborator